Systematic Review and Meta-Analysis: Association between Preoperative Ustekinumab and Surgical Complications in Crohn’s Disease Patients
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review and Meta-Analysis: Association between Preoperative Ustekinumab and Surgical Complications in Crohn’s Disease Patients
Authors
Keywords
-
Journal
EUROPEAN SURGICAL RESEARCH
Volume -, Issue -, Pages 1-10
Publisher
S. Karger AG
Online
2023-10-12
DOI
10.1159/000533594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn’s Disease in the Era of Biologic Therapy
- (2022) Mohamed A Abd El Aziz et al. Journal of Crohns & Colitis
- Hypoalbuminemia, Not Biologic Exposure, is Associated with Postoperative Complications in Crohn’s Disease Patients Undergoing Ileocolic Resection
- (2021) Ravi S Shah et al. Journal of Crohns & Colitis
- Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
- (2021) Anthony Buisson et al. United European Gastroenterology Journal
- The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
- (2021) Daniele Noviello et al. Frontiers in Immunology
- Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis
- (2021) Daxin Guo et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
- (2021) María José García et al. Journal of Clinical Medicine
- Major Surgical Trauma Impairs the Function of Natural Killer Cells but Does Not Affect Monocyte Cytokine Synthesis
- (2021) Roman M. Müller-Heck et al. Life-Basel
- Vedolizumab Induced Clinical, Endoscopic, and Histological Improvement in Common Variable Immunodeficiency Disease–associated Intestinal Enteropathy
- (2020) Hisham Javed Akhtar et al. INFLAMMATORY BOWEL DISEASES
- A comprehensive review and update on Crohn's disease
- (2018) Mahesh Gajendran et al. DM DISEASE-A-MONTH
- Anti-interleukin-12 and anti-interleukin-23 agents in Crohn’s disease
- (2018) Fabio Salvatore Macaluso et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis
- (2018) Matteo Novello et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn’s Disease
- (2017) Amy L Lightner et al. Journal of Crohns & Colitis
- Inflammatory and Immune Responses to Surgery and Their Clinical Impact
- (2016) William Alazawi et al. ANNALS OF SURGERY
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970–2004)
- (2012) Laurent Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Discovery and mechanism of ustekinumab
- (2012) Jacqueline M. Benson et al. mAbs
- Surgery for Crohn’s disease in the era of biologicals: A reduced need or delayed verdict?
- (2012) Anthony de Buck van Overstraeten WORLD JOURNAL OF GASTROENTEROLOGY
- Minimally invasive colectomy for Crohnʼs colitis: A single institution experience
- (2010) Stefan D. Holubar et al. INFLAMMATORY BOWEL DISEASES
- Neuroimmune mechanisms in postoperative ileus
- (2009) G E Boeckxstaens et al. GUT
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started